from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1581c/-

LFCtreatmentdescriptionclass of inhibitor

0.788

Amikacinug/mL Amikacintranslation

0.964

Cap5-10ug/mL Capreomycintranslation

0.673

Rox10-50 ug/mL Roxithromycintranslation

0.148

SM2-5 ug/mL Streptomycintranslation

0.395

Tet5-10 ug/mL Tetracyclinetranslation

-0.526

Rif0.2-5ug/mL Rifampicintranscription

-0.197

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.296

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.658

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.330

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.729

Clofazimine10-13 ug/mL Clofaziminerespiration

1.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.253

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.928

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.387

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.196

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.781

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.180

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.296

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.420

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.186

KCN5-20 ug/mL Potassium cyaniderespiration

0.736

NaN30.2-2 mM Sodium aziderespiration

0.317

Nigericin50 uM Nigericinrespiration

-0.311

TRC10-150 ug/mL Triclosanrespiration

-0.778

TRZ10-25 ug/mL Thioridazinerespiration

2.007

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.175

menadione6-10 ug/mL Menadionerespiration

-0.091

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.391

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.665

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.100

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.693

NRP_1Non-replicating persistence stage 1dosRassociated

-0.124

Amp0.2mg/mL AmpicillincellWall

0.155

Cephalexin20-100 ug/mL CephalexincellWall

-0.094

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.340

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.199

EMB10-20 ug/mL EthambutolcellWall

-0.265

Eta12-40 ug/mL EthionamidecellWall

-0.279

INH0.2-0.4 ug/mL IsoniazidcellWall

0.152

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.942

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.186

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.167

BZA0.12 mg/mL BenzamidearomaticAmides

-0.597

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.588

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.657

H2O24 mM hydrogen peroxideDNAdamaging

0.821

Levo10 ug/mL LevofloxacinDNAdamaging

-0.717

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.623

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.344

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.169

UVUV-irradiationDNAdamaging

-0.143

ARP41-4 ug/mL Antitubercular compound ARP4?

0.353

Antimycin12.5-50 ug/mL Antimycin A?

0.573

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.487

PA_110-50 ug/mL Antitubercular compound PA-1?

0.887

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.103

PA8240.2-2 ug/mL PA-824?

-0.517

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.422

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.217

Verapamil50 uM Verapamil?

0.225

mercaptoethanol2 mM 2-Mercaptoethanol?

1.095

methoxatin10-20 ug/mL Methoxatin?